Swiss National Bank Editas Medicine, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Swiss National Bank holds 153,700 shares of EDIT stock, worth $370,417. This represents 0.0% of its overall portfolio holdings.

Number of Shares

153,700

Previous 153,700 -0.0%

Holding current value

$370,417

Previous $717,000 26.92%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$4.67 - $7.28 $41,563 - $64,792	8,900 Added 6.15%	153,700 $717,000
Q4 2023 Feb 06, 2024	SELL	$6.25 - $11.11 $215,000 - $382,184	-34,400 Reduced 19.2%	144,800 $1.47 Million
Q3 2023 Nov 08, 2023	BUY	$6.92 - $9.31 $13,148 - $17,689	1,900 Added 1.07%	179,200 $1.4 Million
Q2 2023 Aug 09, 2023	BUY	$6.36 - $11.47 $183,804 - $331,483	28,900 Added 19.47%	177,300 $1.46 Million
Q1 2023 May 10, 2023	SELL	$7.03 - $11.53 $123,728 - $202,928	-17,600 Reduced 10.6%	148,400 $1.08 Million
Q4 2022 Feb 08, 2023	BUY	$8.32 - $13.21 $35,776 - $56,803	4,300 Added 2.66%	166,000 $1.47 Million
Q1 2022 May 09, 2022	BUY	$14.08 - $27.63 $167,552 - $328,797	11,900 Added 7.94%	161,700 $3.08 Million
Q3 2021 Nov 08, 2021	BUY	$39.27 - $72.94 $51,051 - $94,822	1,300 Added 0.88%	149,800 $6.15 Million
Q2 2021 Aug 06, 2021	BUY	$31.29 - $56.64 $190,869 - $345,504	6,100 Added 4.28%	148,500 $8.41 Million
Q1 2021 May 07, 2021	BUY	$39.71 - $90.58 $63,536 - $144,928	1,600 Added 1.14%	142,400 $5.98 Million
Q4 2020 Feb 05, 2021	BUY	$27.07 - $84.35 $70,382 - $219,309	2,600 Added 1.88%	140,800 $9.87 Million
Q3 2020 Nov 09, 2020	BUY	$28.06 - $37.16 $47,702 - $63,171	1,700 Added 1.25%	138,200 $3.88 Million
Q2 2020 Aug 05, 2020	BUY	$18.5 - $34.34 $869,500 - $1.61 Million	47,000 Added 52.51%	136,500 $4.04 Million
Q1 2020 May 08, 2020	BUY	$14.88 - $32.78 $62,496 - $137,676	4,200 Added 4.92%	89,500 $1.78 Million
Q4 2019 Feb 06, 2020	BUY	$19.49 - $32.63 $42,878 - $71,786	2,200 Added 2.65%	85,300 $2.53 Million
Q3 2019 Nov 12, 2019	BUY	$22.49 - $26.81 $69,719 - $83,111	3,100 Added 3.88%	83,100 $1.89 Million
Q2 2019 Aug 02, 2019	BUY	$20.48 - $27.76 $299,008 - $405,296	14,600 Added 22.32%	80,000 $1.98 Million
Q1 2019 May 10, 2019	BUY	$19.43 - $26.41 $42,746 - $58,102	2,200 Added 3.48%	65,400 $1.6 Million
Q4 2018 Feb 13, 2019	BUY	$18.19 - $31.79 $25,466 - $44,506	1,400 Added 2.27%	63,200 $1.44 Million
Q3 2018 Nov 08, 2018	BUY	$27.65 - $38.39 $71,890 - $99,814	2,600 Added 4.39%	61,800 $1.97 Million
Q2 2018 Aug 09, 2018	BUY	$31.4 - $41.01 $452,160 - $590,544	14,400 Added 32.14%	59,200 $2.12 Million
Q4 2017 Feb 07, 2018	BUY	$21.89 - $31.34 $102,883 - $147,298	4,700 Added 11.72%	44,800 $1.38 Million
Q3 2017 Nov 03, 2017	BUY	$15.81 - $24.01 $633,981 - $962,801	40,100	40,100 $963,000

Others Institutions Holding EDIT

# of Institutions

247

Shares Held

57M

Call Options Held

410K

Put Options Held

394K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $166M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Editas Medicine, Inc. Transaction History